Two independent studies show that ephrin-B2 controls the internalization and signaling of two types of vascular endothelial growth factor (VEGF) receptors—thereby regulating VEGF-induced ...

Yet there has been no clear molecular explanation for such diversity at the level of vascular endothelial growth factor A (VEGF-A) and other established regulators of angiogenesis that are ...

Purpose: To review the literature regarding ocular hypertension following intravitreal antivascular endothelial growth ... that repeated and long-term VEGF antagonism may lead to a deficiency ...

8月15日，上海交通大学医学院贺兼理/王田实/程金科团队合作在美国临床研究学会出版的Journal of Clinical Investigation期刊上发表 ...

Cell proliferation assay using human umbilical vein endothelial cells (HUVEC). Image Credit: Sino Biological Inc. Inhibit the VEGF-dependent proliferation of human umbilical vein endothelial cells ...

Intravitreal injections of anti-VEGF agents have become an important tool in the management of some of the most common retinal and choroidal neovascular diseases. Adverse effects are uncommon ...

This difference becomes clear in pulmonary hypertension, in which only the lungs' blood vessels stiffen progressively, leading ... Researchers Identify Over 2,000 Genetic Signals Linked to Blood ...

B: Induction of VEGF-D translation in Adipo-VD mice elevates Vegf-d and lymphatic endothelial cell marker RNAs in inguinal white adipose tissue. C: Brown adipose tissue exhibits higher VEGF-D RNA ...

Pulmonary hypertension (PH) is a condition that occurs when your blood pressure in the blood vessels between the heart and ...

Could Blood Pressure Medication Increase Your Wet AMD Risk? Could the medication you take for hypertension be affecting your vision? Explore the potential link between blood pressure medicine and ...

The pulmonary medicine focuses on the common and complex diseases of the lung. Examples include asthma, chronic obstructive lung disease, cystic fibrosis, pulmonary hypertension and others. Are you ...

Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...